Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
47 hedge funds and large institutions have $6.32M invested in Nymox Pharmaceutical Corp in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 8 closing their positions.
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
22% more capital invested
Capital invested by funds: $5.19M → $6.32M (+$1.14M)
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
4% more funds holding
Funds holding: 45 → 47 (+2)
12% less call options, than puts
Call options by funds: $99K | Put options by funds: $113K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$644K |
| 2 |
Goldman Sachs
New York
|
+$336K |
| 3 |
Renaissance Technologies
New York
|
+$194K |
| 4 |
Millennium Management
New York
|
+$125K |
| 5 |
FCFC
First Citizens Financial Corp
Mason City,
Iowa
|
+$98.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$189K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$118K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$116K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$98.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$80.6K |
NYMX Hedge Fund Activity: Q1 2020 in Review
47 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2020, worth a combined $6.32M — up 22% from $5.19M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NYMX positions and 8 closed out — a net gain of 4 holders — while 10 added to existing stakes and 9 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $644K. The largest seller was 683 Capital Management, exiting entirely with an estimated $189K sold.
- 47 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2020, up from 45 in Q4 2019.
- Funds reported $6.32M of Nymox Pharmaceutical Corp stock for Q1 2020, up 22% quarter-over-quarter.
- 12 funds opened new Nymox Pharmaceutical Corp positions in Q1 2020 and 8 closed out, a net change of +4 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q1 2020 was Susquehanna International Group, an estimated $644K added.
- The largest Nymox Pharmaceutical Corp seller in Q1 2020 was 683 Capital Management, an estimated $189K sold.
Based on aggregated 13F filings for Q1 2020.